Delivery Order SPE2DB20D1109-SPE2DB23FP98U
Award Date
9/21/23
Potential Completion Date
9/22/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,489.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554834923 - MICROGESTIN FE 1-20 TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,514.81 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 27, 2023, with a completion date of September 28, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,139.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 5, 2025. The contract covers the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,045.23, is a delivery order for the supply of MICROGESTIN FE 1-20 Tablets, a generic contraceptive medication. This contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora,...
This federal contract award, with ID SPE2DB20D7059|SPE2DB23FQKV9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MICROGESTIN FE 1-20 TABLET 28S, with a ceiling value of $16,385.73 and a period of performance through October 2, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside...
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,288.48 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2021, with a completion date of November 17, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,525.94, is a Delivery Order for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,009.19 Firm Fixed Price Delivery Order contract covers the provision of MICROGESTIN FE 1.5-30 TAB 28S, a type of prescription medication, with a period of performance through February 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.47, is for the delivery of Microgestin FE 1.5-30 tablets (28s). The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025....
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency (DLA) is for the delivery of pharmaceutical products, including Microgestin FE 1-20 tablets, with a ceiling value of $1,929.72. The contract is a firm fixed-price Delivery Order with a completion date of December 22, 2021. This award is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen maintains a significant Indefinite...